J. Nash

发表

Correlation of subjective and objective sleep measurements at different stages of the treatment of depression

David J. Nutt, D. Nutt, Sue J. Wilson, 2003, Psychiatry Research.

PHARMACOLOGY AND CELL METABOLISM Assessment of GABAA Benzodiazepine Receptor (GBzR) Sensitivity in Patients with Alcohol Dependence

D. Nutt, A. Lingford-Hughes, J. Nash, 2008 .

Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence.

D. Nutt, A. Lingford-Hughes, J. Nash, 2008, Alcohol and alcoholism.

Inhalation of 35% CO2 results in activation of the HPA axis in healthy volunteers

D. Nutt, S. Argyropoulos, S. Lightman, 2002, Psychoneuroendocrinology.

Pharmacotherapy of Anxiety

D. Nutt, J. Nash, 2007 .

The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description

T. Robbins, R. Elliott, D. Nutt, 2016, Journal of psychopharmacology.

Management of panic disorder in primary care

D. Nutt, J. Nash, S. Davies, 2017 .

Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders

D. Nutt, C. Bell, S. Argyropoulos, 1999, European Neuropsychopharmacology.

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

D. Nutt, U. Müller, E. Sonuga-Barke, 2014, Journal of psychopharmacology.

The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description

John Suckling, Rebecca Elliott, Trevor W Robbins, 2016, Journal of psychopharmacology.

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.

D. Nutt, C. Bell, S. Argyropoulos, 2002, The British journal of psychiatry : the journal of mental science.

Development and validation of the Generalized Anxiety Disorder Inventory (GADI)

D. Nutt, I. Anderson, S. Argyropoulos, 2006, Journal of psychopharmacology.

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study.

D. Nutt, P. Grasby, E. Rabiner, 2008, The British journal of psychiatry : the journal of mental science.

Serotonin 5-HT 1 A receptor binding in people with panic disorder : positron emission tomography study

D. Nutt, P. Grasby, E. Rabiner, 2008 .

Caffeine and Central Noradrenaline: Effects on Mood, Cognitive Performance, Eye Movements and Cardiovascular Function

Andrew P. Smith, D. Nutt, J. Nash, 2003, Journal of psychopharmacology.

Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism

D. Nutt, Sue J. Wilson, J. Nash, 2003, Neurology.

P3.044 Alttered 5HT1A binding in panic disorderdemonstrated by positron emission tomography

E. Rabiner, J. Nash, S. Hood, 2004, European Neuropsychopharmacology.

The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans

D. Nutt, Sue J. Wilson, J. Nash, 2005, Journal of psychopharmacology.

Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder

D. Nutt, C. Bell, S. Argyropoulos, 2004, Biological Psychiatry.

Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder

D. Nutt, C. Bell, S. Argyropoulos, 2011, Psychopharmacology.

Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine

D. Nutt, C. Bell, S. Argyropoulos, 2002, Journal of psychopharmacology.

Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone

D. Nutt, Sue J. Wilson, C. Bell, 2009, Journal of sleep research.

Pharmacotherapy of anxiety.

D. Nutt, J. Nash, J. Nash, 2007, Handbook of experimental pharmacology.

Development and validation of the Generalized Anxiety Disorder Inventory (GADI)

D. Nutt, I. Anderson, S. Argyropoulos, 2006, Journal of psychopharmacology.

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

D. Nutt, U. Müller, E. Sonuga-Barke, 2014, Journal of psychopharmacology.

The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description

R. Elliott, A. Lingford-Hughes, K. Ersche, 2016, Journal of psychopharmacology.